α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 31 março 2025

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

The Cardiac β-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery - ScienceDirect

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Modulation of β-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action - ScienceDirect

Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Quantitative Determination of Endoplasmic Reticulum Viscosity during Immunogenic Cell Death by a Theranostic Rhenium Complex

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

SciELO - Brasil - Neurohumoral activation in heart failure: the role of adrenergic receptors Neurohumoral activation in heart failure: the role of adrenergic receptors